stoxline Quote Chart Rank Option Currency Glossary
  
Frazier Lifesciences Acquisition Corporation (FLACU)
9.5  0.23 (2.48%)    11-22 15:59
Open: 10
High: 10.8
Volume: 18,201
  
Pre. Close: 9.2701
Low: 8.07
Market Cap: 0(M)
Technical analysis
2022-04-29 4:22:59 PM
Short term     
Mid term     
Targets 6-month :  11.68 1-year :  13.64
Resists First :  10 Second :  11.68
Pivot price 9.92
Supports First :  9.9 Second :  9.85
MAs MA(5) :  9.95 MA(20) :  9.94
MA(100) :  9.94 MA(250) :  10
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  53.8 D(3) :  58.9
RSI RSI(14): 51.8
52-week High :  10.64 Low :  9.85
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ FLACU ] has closed below upper band by 42.0%. Bollinger Bands are 29.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 9.97 - 10.02 10.02 - 10.06
Low: 9.82 - 9.88 9.88 - 9.93
Close: 9.86 - 9.94 9.94 - 10.02
Company Description

Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.

Headline News

Thu, 13 Jul 2023
Gilead Boosts Biotech Footprint With Stakes In AlloVir And Arcus - Nasdaq

Wed, 09 Dec 2020
Record IPO & SPAC Bubble Fattened by Ridiculous DoorDash IPO. Airbnb Next - WOLF STREET

Wed, 09 Dec 2020
Biotech SPAC Frazier Lifesciences Acquisition prices upsized $120 million IPO at $10 - Renaissance Capital

Wed, 09 Dec 2020
Frazier Lifesciences Acquisition Corporation Announces Pricing of Upsized $120 Million Initial Public Offering - Business Wire

Tue, 24 Nov 2020
A SPAC called FLAC? Seattle venture capital firm to launch $100 million 'blank check' company - GeekWire

Fri, 20 Nov 2020
US IPO Weekly Recap: Breast cancer biotech pops 158% in a 6 IPO week - Renaissance Capital

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Financial Services
Industry:
Shell Companies
Shares Out 0 (M)
Shares Float 14 (M)
Held by Insiders 0 (%)
Held by Institutions 61.9 (%)
Shares Short 1 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.41
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow -2 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value -24.25
Price to Sales 0
Price to Cash Flow -0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android